Immunosuppressive effects induced by the polysaccharide moiety of some bacterial lipopolysaccharides.

[1]  A. Hasegawa,et al.  Structural features that influence the ability of lipid A and its analogs to abolish expression of suppressor T cell activity , 1992, Infection and immunity.

[2]  C. Galanos,et al.  Comparative immunochemistry of lipopolysaccharides from Branhamella catarrhalis strains , 1991, Infection and immunity.

[3]  P. Baker,et al.  Differential sensitivity of CD8+ suppressor and cytotoxic T lymphocyte activity to bacterial monophosphoryl lipid A , 1991, Infection and immunity.

[4]  P. Baker,et al.  Differential effects of monophosphoryl lipid A on expression of suppressor T cell activity in lipopolysaccharide-responsive and lipopolysaccharide-defective strains of C3H mice , 1991, Infection and Immunity.

[5]  P. Baker,et al.  Antigen-specific suppressor T cells respond to recombinant interleukin-2 and other lymphokines , 1991, Infection and immunity.

[6]  R. S. Conrad,et al.  Relationship Between Chemical Composition and Biological Function of Pseudomonas aeruginosa Lipopolysaccharide: Effect on Human Neutrophil Chemotaxis and Oxidative Burst , 1991, Journal of Leukocyte Biology.

[7]  P. Baker,et al.  T cells regulate the IgM antibody response of BALB/c mice to dextran B1355. , 1990, Immunobiology.

[8]  C. Galanos,et al.  Modification of the silver staining technique to detect lipopolysaccharide in polyacrylamide gels , 1990, Journal of clinical microbiology.

[9]  P. Baker.  Regulation of magnitude of antibody response to bacterial polysaccharide antigens by thymus-derived lymphocytes , 1990, Infection and immunity.

[10]  N. Qureshi,et al.  Inactivation of suppressor T cell activity by the nontoxic lipopolysaccharide of Rhodopseudomonas sphaeroides , 1990, Infection and immunity.

[11]  K. Amano,et al.  Biochemical and immunological comparison of lipopolysaccharides from Bordetella species. , 1990, Journal of general microbiology.

[12]  P. Baker,et al.  Enrichment of suppressor T cells by means of binding to monophosphoryl lipid A , 1990, Infection and immunity.

[13]  M. Matsuura,et al.  内毒素の活性中心(リピドA)の研究 , 1989 .

[14]  R. S. Conrad,et al.  Longitudinal study of antibody response to lipopolysaccharides during chronic Pseudomonas aeruginosa lung infection in cystic fibrosis , 1988, Infection and immunity.

[15]  N. Qureshi,et al.  Complete structural determination of lipopolysaccharide obtained from deep rough mutant of Escherichia coli. Purification by high performance liquid chromatography and direct analysis by plasma desorption mass spectrometry. , 1988, The Journal of biological chemistry.

[16]  J. Hiernaux,et al.  Inactivation of suppressor T-cell activity by nontoxic monophosphoryl lipid A , 1988, Infection and immunity.

[17]  R. S. Conrad,et al.  Comparative immunochemistry of lipopolysaccharides from typable and polyagglutinable Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis , 1988, Journal of clinical microbiology.

[18]  H. Friedman,et al.  Enhanced Antibody Response in Retrovirus-Infected Mice Treated with Endotoxin or Nontoxic Polysaccharide Derivative , 1987, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[19]  A. Nowotny.  Review of the molecular requirements of endotoxic actions. , 1987, Reviews of infectious diseases.

[20]  P. Baker,et al.  Increased activation of antigen-primed or memory B cells by bacterial lipopolysaccharide. , 1987, Cellular immunology.

[21]  J. Cavaillon,et al.  Specific binding of endotoxin to human monocytes and mouse macrophages: serum requirement. , 1985, Cellular immunology.

[22]  J. Cavaillon,et al.  Interleukin 1 secretion by human monocytes stimulated by the isolated polysaccharide region of the Bordetella pertussis endotoxin. , 1984, Molecular immunology.

[23]  K. Shimokata,et al.  Paradoxical effects of LPS on the T-cell-independent type 2 anti-H-2 alloantigen antibody responses to allogeneic erythrocytes. , 1984, Transplantation.

[24]  R. Hancock,et al.  Pseudomonas aeruginosa isolates from patients with cystic fibrosis: a class of serum-sensitive, nontypable strains deficient in lipopolysaccharide O side chains , 1983, Infection and immunity.

[25]  P. Baker,et al.  Activation of antigen-specific suppressor T cells by B cells from mice immunized with type III pneumococcal polysaccharide , 1983, The Journal of experimental medicine.

[26]  P. Baker,et al.  Cell surface antigens and other characteristics of T cells regulating the antibody response to type III pneumococcal polysaccharide. , 1983, Journal of Immunology.

[27]  F. Madani,et al.  Studies on the optimal conditions of CSF generation by endotoxic LPS and its PS derivative in mice. , 1983, Journal of immunopharmacology.

[28]  J. Cavaillon,et al.  Macrophage-dependent polyclonal activation of splenocytes by Bordetella pertussis endotoxin and its isolated polysaccharide and Lipid A regions. , 1982, Cellular immunology.

[29]  P. Baker,et al.  Direct evidence for the involvement of T suppressor cells in the expression of low-dose paralysis to type III pneumococcal polysaccharide. , 1982, Journal of immunology.

[30]  I. Nakashima,et al.  Adjuvant action of bacterial lipopolysaccharide in induction of delayed-type hypersensitivity to protein antigens. , 1982, Cellular immunology.

[31]  C. Frasch,et al.  A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. , 1982, Analytical biochemistry.

[32]  P. Baker,et al.  Regulation of the antibody response to pneumococcal polysaccharide by thymus-derived cells. , 1981, Reviews of infectious diseases.

[33]  R. Chaby,et al.  Mitogenic response of C3H/HeJ mouse lymphocytes to polyanionic polysaccharides obtained from Bordetella pertussis endotoxin and from other bacterial species , 1981, Infection and immunity.

[34]  I. Nakashima,et al.  Adjuvant actions of polyclonal lymphocyte activators. II. Comparison and characterization of their actions in initiation and potentiation of immune responses to T-dependent and T-independent soluble antigens. , 1980, Cellular immunology.

[35]  R. Scibienski.  Immunologic properties of protein-linopolysaccharide complexes--III. Role of carbohydrate in the LPS adjuvant effect. , 1980, Molecular immunology.

[36]  J. Mcghee,et al.  Cellular requirements for lipopolysaccharide adjuvanticity. A role for both T lymphocytes and macrophages for in vitro responses to particulate antigens , 1979, The Journal of experimental medicine.

[37]  D. Morrison,et al.  Bacterial endotoxins and host immune responses. , 1979, Advances in immunology.

[38]  P. Baker,et al.  Effect of splenectomy on the expression of regulatory T cell activity. , 1978, Journal of immunology.

[39]  L. Kline,et al.  Activation of the classical and properdin pathways of complement by bacterial lipopolysaccharides (LPS). , 1977, Journal of immunology.

[40]  D. Jacobs,et al.  Isolation of a lipid a bound polypeptide responsible for “LPS- initiated” mitogenesis of C3H/HeJ spleen cells , 1976, The Journal of experimental medicine.

[41]  B. M. Sultzer,et al.  Endotoxin protein: a B-cell mitogen and polyclonal activator of C3H/HeJ lymphocytes , 1976, The Journal of experimental medicine.

[42]  A. Coutinho,et al.  A plaque assay for all cells secreting Ig of a given type or class , 1976, European journal of immunology.

[43]  J. Jones,et al.  Kinetics of the antibody response to type III pneumococcal polysaccharide. II. Factors influencing the serum antibody levels after immunization with an optimally immunogenic dose of antigen. , 1976, Journal of immunology.

[44]  J. Watson,et al.  Genetic Linkage between the In Vitro Mitogenic and In Vivo Adjuvant Properties of LPS * , 2003 .

[45]  C. Galanos,et al.  Electrodialysis of lipopolysaccharides and their conversion to uniform salt forms. , 1975, European journal of biochemistry.

[46]  D. Katz,et al.  ACTIVATION OF T AND B LYMPHOCYTES IN VITRO , 1974, The Journal of experimental medicine.

[47]  C. Gottlieb.  Application of transformations to normalize the distribution of plaque-forming cells. , 1974, Journal of immunology.

[48]  J. Watson,et al.  The role of humoral factors in the initiation of in vitro primary immune responses. II. Effects of lymphocyte mitogens. , 1973, Journal of immunology.

[49]  G. Möller,et al.  Induction of immunoglobulin and antibody synthesis in vitro by lipopolysaccharides , 1972, European journal of immunology.

[50]  A. Allison,et al.  Requirement of Thymus-dependent Lymphocytes for Potentiation by Adjuvants of Antibody Formation , 1971, Nature.

[51]  P. Baker,et al.  Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. II. Studies on the relative rate of antibody synthesis and release by antibody-producing cells. , 1971, Immunology.

[52]  P. Baker,et al.  Characterization of the antibody response to type 3 pneumococcal polysaccharide at the cellular level. I. Dose-response studies and the effect of prior immunization on the magnitude of the antibody response. , 1971, Immunology.

[53]  P. Baker,et al.  Quantitative and Qualitative Studies on the Primary Antibody Response to Pneumococcal Polysaccharides at the Cellular Level , 1969, The Journal of Immunology.

[54]  C. Galanos,et al.  A new method for the extraction of R lipopolysaccharides. , 1969, European journal of biochemistry.

[55]  P. Baker,et al.  Use of erythrocytes sensitized with purified pneumococcal polysaccharides for the assay of antibody and antibody-producing cells. , 1969, Applied microbiology.

[56]  O. Westphal.  Bacterial lipopolysaccharides : extraction with phenol-water and further applications of the procedure , 1965 .